Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Covington
McKesson
Cipla
Julphar
Chinese Patent Office
QuintilesIMS
Federal Trade Commission
Farmers Insurance
Colorcon

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062338

« Back to Dashboard

NDA 062338 describes ERYC, which is a drug marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, and Johnson And Johnson, and is included in seven NDAs. It is available from one supplier. Additional details are available on the ERYC profile page.

The generic ingredient in ERYC is erythromycin. There are one hundred and one drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062338
Tradename:ERYC
Applicant:Warner Chilcott Llc
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062338

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Baxter
Covington
Citi
Merck
Cipla
Teva
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot